PBAC Public Summary Documents - July 2008

Public summary documents relating to the July 2008 PBAC meeting

Page last updated: 31 October 2008

• Adalimumab, injection, 40 mg in 0.8 mL pre-filled syringe, 40 mg in 0.8 mL pre-filled pen, Humira®
• Myozyme Alglucosidase alfa alfa, powder for I.V. infusion, 50 mg, Myozyme®
• Amlodipine besylate with Valsartan, tablet, 5 mg-80 mg, 5 mg-160 mg, 10 mg-160 mg, Exforge® 5/80, Exforge®5/160, Exforge®10/160
• Atomoxetine hydrochloride, capsules, 80 mg and 100 mg, Strattera®
• Bevacizumab, solution for I.V. infusion, 100 mg in 4 mL, 400 mg in 16 mL, Avastin®
• Botulinum toxin type A purified neurotoxin complex, lyophilised powder for IM injection, 100 units vial, Botox®
• Botulinum (upper) toxin type a purified neurotoxin complex, Lyophilised powder for I.M. injection 100 units vial, Botox®
• Carmustine, implant, 7.7 mg, 8, Gliadel ®
• Docetaxel, injection set containing 1 single use vial concentrate for I.V. infusion 20 mg (anhydrous) in 0.5 mL and 1 single use vial solvent 1.5 mL, injection set containing 1 single use vial concentrate for I.V. infusion 80 mg (anhydrous) in 2 mL and 1 single use vial solvent 6 mL, Taxotere®
• Doxorubicin hydrochloride, pegylated liposomal, suspension for I.V. infusion, 20 mg in 10 mL and 50 mg in 25 mL, Caelyx®
• Eculizumab, solution concentrate for I.V. infusion, 300 mg in 30 mL, Soliris®
• Etanercept, injection set containing 4 vials powder for injection 25 mg and 50 mg and 4 pre-filled syringes solvent 1 mL, and injection 50 mg in 1 mL single use pre-filled syringes, 4, Enbrel®
• Etanercept, injection set containing 4 vials powder for injection 25 mg and 50 mg and 4 pre-filled syringes solvent 1 mL, and injection 50 mg in 1 mL single use pre-filled syringes, 4, Enbrel^®
• Etoricoxib, tablet, 30 mg, 60 mg, Arcoxia®
• Imiquimod, cream 50 mg per g (5%), 250 mg single use sachets, 12, AldaraTM
• Infliximab, powder for IV infusion, 100 mg, Remicade®
• Ivabradine hydrochloride, film coated tablets, 5 mg and 7.5 mg, Coralan®
• Methoxyflurane, solution, 1 x 3 mL with inhaler, Penthrox®
• Pramipexole hydrochloride, tablet, 125 micrograms, 250 micrograms and 1 mg, Sifrol®, July 2008
• Ribavirin capsules 200 mg, (various quantities) and peginterferon alfa-2b, single use injection pens containing powder for injection in 50, 80, 100, 120 and 150 micrograms, Pegatron®
• Risedronate sodium, tablet, 5 mg, (Actonel®) and 35 mg (Actonel Once-a-week®), Risedronate sodium and Calcium carbonate, pack containing 4 tablets risedronate sodium 35 mg and 24 tablets calcium carbonate 1.25 g (equivalent to 500 mg calcium), (Actonel Combi®)
• Sorafenib tosylate, tablet, 200 mg (base), Nexavar®
• Sunitinib malate, capsules, 12.5 mg, 25 mg and 50 mg (base), Sutent®
• Temsirolimus, injection set containing 1 vial of powder for IV infusion 25 mg and 1 vial diluent, Torisel®
• Valsartan with hydrochlorothiazide, tablets, 80 mg - 12.5 mg, 160 mg - 12.5 mg and 160 mg – 25 mg Co-Diovan®
• Zoledronic acid, solution for I.V infusion, 5 mg in 100 mL, Aclasta®